• Explore /
  • Poster
  • / Clinical efficacy and safety of early adjuvant chemotherapy for stage III colon cancer: Short-term outcomes of a multicenter, randomized, open-label, phase 3 trial.

Clinical efficacy and safety of early adjuvant chemotherapy for stage III colon cancer: Short-term outcomes of a multicenter, randomized, open-label, phase 3 trial.

Abstract Poster

Authors

null

Jun Seok Park

Colorectal Cancer Center, Kyungpook National University Medical Center, Daegu, South Korea

Jun Seok Park , Soo Yeun Park , Gyu-Seog Choi , Hye Jin Kim , Jong Gwang Kim , Byung Woog Kang , In Kyu Lee , Yoon Suk Lee , Sohyun Kim , Seong Kyu Baek , Gyung Mo Son , Ki Beom Bae , Ji Yeon Kim , Kyung-ha Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer - Neo-Adjuvant/Adjuvant

Clinical Trial Registration Number

NCT01460589

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3598)

DOI

10.1200/JCO.2021.39.15_suppl.3598

Abstract #

3598

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Soo Yeun Park

First Author: Jennifer Leigh Lund

First Author: Jaafar Bennouna

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.

Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.

First Author: Daniel Walden